AU Patent

AU2024235143A1 — Pharmaceutical compositions and methods for the treatment of metabolic and liver disorders

Assigned to Viking Therapeutics Inc · Expires 2025-09-11 · 1y expired

What this patent protects

Disclosed herein are oral compositions of small molecule GLP-1 agonists and GIP/GLP-1 dual receptor agonists and uses thereof.

USPTO Abstract

Disclosed herein are oral compositions of small molecule GLP-1 agonists and GIP/GLP-1 dual receptor agonists and uses thereof.

Drugs covered by this patent

Patent Metadata

Patent number
AU2024235143A1
Jurisdiction
AU
Classification
—
Expires
2025-09-11
Drug substance claim
No
Drug product claim
No
Assignee
Viking Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.